DEFA14A ·Filed Apr 23, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any unexpected director nominations or shareholder proposals in future filings, but this routine proxy statement has no immediate financial implications.
Final — all horizons settled through T+60d
AMLX ▲ +0.75% at T+60d
NEUTRAL call +0.75% · α vs SPY -4.27% · entry $17.32 → $17.45
T+1d
-1.62%
call -1.62% · α -2.40%
$17.04
settled 6mo ago
T+5d
-9.93%
call -9.93% · α -11.41%
$15.60
settled 6mo ago
T+20d
-21.42%
call -21.42% · α -26.05%
$13.61
settled 5mo ago
T+60d
+0.75%
call +0.75% · α -4.27%
$17.45
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Amylyx Pharmaceuticals is holding its 2026 annual shareholder meeting to vote on director elections, auditor ratification, and executive compensation. This is a routine proxy filing with no material financial impact.
Key Financial Metrics
Vote
director election
Meeting
2026-06-04
Key Facts
- 2026 Annual Meeting of Stockholders to be held virtually on June 4, 2026
- Board recommends voting FOR all nominees and proposals
- Proposal 1: Elect George Mclean Milne Jr. and Paul Fonteyne as Class II directors
- Proposal 2: Ratify appointment of Deloitte & Touche LLP as independent auditor
- Proposal 3: Approve non-binding advisory vote on executive compensation
Financial Impact
No material financial impact
Risk Factors
- Potential for shareholder activism if executive compensation is perceived as excessive
- Risk of auditor resignation if Deloitte & Touche is not ratified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-171803 |
| Document: 0001193125-26-171803-index-headers.html | 0001193125-26-171803 |
| Document: 0001193125-26-171803-index.html | 0001193125-26-171803 |
| Document: 0001193125-26-171803.txt | 0001193125-26-171803 |
10 reports for AMLX
67% Hit rate @ T+20 Went positive at some point 3 of 3 best @ T+5▲ +78.02%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 144 | $28.04 | awaiting T+20 | — | $27.09 (−3.39%) |
Sep 14, 2026 6w ago | Insider Cluster | $33.15 $26.85 | ▼ −19.00% | ▼ −21.73% | $27.09 (−18.28%) |
Sep 11, 2026 6w ago | 144 | $33.64 $27.48 | ▼ −18.31% | ▼ −20.57% | $27.09 (−19.47%) |
Aug 18, 2026 9w ago | 8-K | $35.11 $33.05 | ▼ −5.87% | ▼ −4.88% | $27.09 (−22.84%) |
Aug 15, 2026 10w ago | Institutional Cluster | $21.43 $33.15 | ▲ +54.69% | ▲ +56.67% | $27.09 (+26.41%) |
Aug 6, 2026 11w ago | 8-K | $24.19 $33.96 | ▲ +40.39% | ▲ +39.79% | $27.09 (+11.99%) |
Jun 11, 2026 19w ago | Institutional Cluster | $13.91 $18.38 | ▲ +32.14% | ▲ +30.24% | $27.09 (+94.75%) |
Apr 23, 2026 26w ago | DEFA14A | $17.32 $13.61 | ▼ −21.42% | ▼ −26.05% | $27.09 (+56.41%) |
Mar 2, 2026 34w ago | Insider Cluster | $15.30 $12.76 | ▼ −16.60% | ▼ −8.66% | $27.09 (+77.06%) |
Feb 23, 2026 35w ago | Insider Cluster | $13.90 $13.53 | ▲ +2.66% | ▼ −1.28% | $27.09 (−94.89%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Tue (16h 36m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers